Trial Profile
Effect of Ezetimibe on Serum Remnant-Like Particle (RLP) Cholesterol in dyslipidemic patients with Diabetes Mellitus or the Metabolic Syndrome (EZREC Study).
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Aug 2009
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- Acronyms EZREC Study
- 10 Aug 2009 New trial record